Last updated 2026-08-23
- Raised $3.6M Pre-Seed round led by FLORA Ventures, Jun 2025
Total raised
$3.6M
Last: Undisclosed Round 2025-06
Stage
Pre-Seed
Founded
2024
Headcount
10
HQ
Tel Mond, Israel
Sector
FoodTech
About
Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, using an AI-powered discovery platform. Its lead product, GLP-1 Edge™, is a food-grade peptide that enhances the body’s GLP-1 response to support appetite regulation and metabolic health. Designed for seamless integration into formats like bars, shakes, and supplements, it enables natural weight management without pharmaceutical intervention.
The company’s proprietary AI platform accelerates the design of targeted peptides, leveraging patent-pending academic technology to expand into additional health applications. Lembas combines computational biology with food science to bring precision bioactives into everyday nutrition.
Funding history · 1 round · $3.6M total
1 event/round · $3.6M Total Funding: $3.6M in Private Equity
Jun 2025
★ FLORA VenturesSDHFresh FundMaia VenturesSiddhi CapitalMandi VenturesBluestein VenturesLongevity Venture Partners
Headcount over time
10 employees (2026-09) · 1 point
Offices
Tel Mond, Israel · HQ / main office
Show all offices (1 more)
- Sheffield, United Kingdom
Q&A
- What is Lembas's primary focus?
- Lembas develops natural, clinically validated bioactive ingredients for functional foods and supplements, utilizing an AI-powered discovery platform. Their lead product, GLP-1 Edge™, is a food-grade peptide designed to support appetite regulation and metabolic health.
- When was Lembas founded?
- Lembas was founded in May 2024.
- How much funding has Lembas raised to date?
- Lembas has raised a total of $3,600,000.
- Which investors participated in Lembas's most recent funding round?
- In June 2025, Lembas raised $3,600,000 in a Pre-Seed round with participation from FLORA Ventures.
- What is Lembas's current employee count?
- Lembas currently has 1-10 employees.
- What is Lembas's primary sector?
- Lembas operates in the Agriculture & Food Technologies sector.
- Where is Lembas headquartered?
- Lembas is headquartered in Tel Mond, Israel.
- Does Lembas have any international offices?
- Yes, Lembas has an office in Sheffield, UK.
Team · 14
Shay Hilel
Founder · Co-Founder, CEO
Dr. Zohar Barbash
Founder · Co-Founder, CTO
Prof. Maayan Gal
Founder · Co-Founder, CSO
Dr. Daniel Bar
Founder · Co-Founder
Gil Horsky
Founder · Founding Chairman
Dr. Eyal Akiva
VP Computational Biology
Dr. Marina Abramov
R&D Project Lead
Eden Goldfarb
Head of Peptides Discovery
Dr. Jan-Willem van Klinken, MD
Medical & Regulatory Affairs
Dikla Haham
R&D Project Manager
Doug Lynch
North America Commercial Lead
Rob Hargrove
Advisory Board Member
Dr Gabriela Liberman-Segal, MD PhD
Clinical Advisor
Prof Arne Astrup
Advisory Board Member
Sectors & technology
Primary sector
FoodTech
Technologies
Target customers
Business model
B2B
Tags
foodtechbiotechnologysupplements
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | hellolembas.com/ |
|---|---|
| linkedin.com/company/106583296 |
Identifiers & details
| Legal name | Lembas Bio LTD |
|---|---|
| Founded | 2024-5 |
| Employees (exact) | 10 |
| Offices | Sheffield |
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | hellolembas.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516987773 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2024-05-26 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הפרדס 13 תל מונד |